论文部分内容阅读
目的:比较头孢丙烯与阿奇霉素对小儿轻中度社区获得性呼吸道感染的临床疗效。方法:选取2015年1月—2016年1月间收治的轻中度社区获得性呼吸道感染患儿126例,按随机数字表法将其分为治疗组与对照组(每组63例);比较两组患儿治疗后的总有效率和不良反应的发生率。结果:治疗组患儿治疗后的总有效率为96.83%高于对照组为80.95%(P<0.05),不良反应的发生率为6.35%稍低于对照组为7.94%(5/63)(P>0.05)。结论:采用头孢丙烯治疗小儿轻中度社区获得性呼吸道感染的临床疗效优于阿奇霉素,且发生的不良反应症状较轻。
Objective: To compare the clinical efficacy of cefprozil with azithromycin in children with mild to moderate community-acquired respiratory tract infections. Methods: A total of 126 children with mild-to-moderate community-acquired respiratory tract infection admitted between January 2015 and January 2016 were selected and divided into treatment group and control group (63 cases in each group) according to random number table. The two groups of children after treatment, the total effective rate and incidence of adverse reactions. Results: The total effective rate of the treatment group was 96.83%, which was 80.95% (P <0.05), the incidence of adverse reactions was 6.35%, which was slightly lower than that of the control group (7.94%, 5/63) P> 0.05). CONCLUSION: Celecoxib is superior to azithromycin in treating mild-to-moderate community-acquired respiratory tract infections in children, and mild symptoms of adverse reactions occur.